Lexicon Pharmaceuticals (LXRX) Debt Ratio (2023 - 2025)
Lexicon Pharmaceuticals (LXRX) has disclosed Debt Ratio for 6 consecutive years, with 0.29 as the latest value for Q4 2025.
- On a quarterly basis, Debt Ratio fell 13.14% to 0.29 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29, a 13.14% decrease, with the full-year FY2025 number at 0.29, down 13.14% from a year prior.
- Debt Ratio was 0.29 for Q4 2025 at Lexicon Pharmaceuticals, up from 0.27 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.43 in Q4 2023 to a low of 0.24 in Q1 2024.
- A 3-year average of 0.31 and a median of 0.31 in 2023 define the central range for Debt Ratio.
- Peak YoY movement for Debt Ratio: fell 22.51% in 2024, then skyrocketed 41.28% in 2025.
- Lexicon Pharmaceuticals' Debt Ratio stood at 0.43 in 2023, then dropped by 22.51% to 0.34 in 2024, then dropped by 13.14% to 0.29 in 2025.
- Per Business Quant, the three most recent readings for LXRX's Debt Ratio are 0.29 (Q4 2025), 0.27 (Q3 2025), and 0.25 (Q2 2025).